BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 9434132)

  • 1. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
    Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
    Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR; Nahorski SR
    Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
    Zhang D; Li JG; Chen C; Liu-Chen LY
    Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-dependent, cholera toxin-catalyzed ADP-ribosylation of pertussis toxin-sensitive G-proteins following transfection of the human alpha 2-C10 adrenergic receptor into rat 1 fibroblasts. Evidence for the direct interaction of a single receptor with two pertussis toxin-sensitive G-proteins, Gi2 and Gi3.
    Milligan G; Carr C; Gould GW; Mullaney I; Lavan BE
    J Biol Chem; 1991 Apr; 266(10):6447-55. PubMed ID: 1848855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of inverse agonism at the delta opioid receptor after expression in Rat 1 fibroblasts.
    Mullaney I; Carr IC; Milligan G
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):227-34. PubMed ID: 8670111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.
    Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR
    Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional modification by cholera-toxin-catalyzed ADP-ribosylation of a guanine-nucleotide-binding regulatory protein serving as the substrate of pertussis toxin.
    Iiri T; Ohoka Y; Ui M; Katada T
    Eur J Biochem; 1991 Dec; 202(2):635-41. PubMed ID: 1662135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.
    Sim LJ; Selley DE; Childers SR
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7242-6. PubMed ID: 7638174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
    J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
    Carter BD; Medzihradsky F
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC; Loh HH; Law PY
    Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An arginine residue is the site of receptor-stimulated, cholera toxin-catalysed ADP-ribosylation of pertussis toxin-sensitive G-proteins.
    Milligan G; Mitchell FM
    Cell Signal; 1993 Jul; 5(4):485-93. PubMed ID: 8396964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli.
    Stanasila L; Lim WK; Neubig RR; Pattus F
    J Neurochem; 2000 Sep; 75(3):1190-9. PubMed ID: 10936202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
    J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.